Hypoxia suppresses the production of matrix metalloproteinases and the migration of humanmonocyte‐derived dendritic cells

As most solid tumors are hypoxic, dendritic cells (DC) in solid tumors are also exposed to hypoxia. While many adaptation responses of tumor cells to hypoxia are known, it is yet to be determined how hypoxia affects the functions of DC. To explore the effects of hypoxia on the functions of DC, we compared the expression of surface markers, cytokines, chemokine receptors and matrix metalloproteinases (MMP) of human monocyte‐derived DC (hmDC) differentiated under hypoxia to those differentiated under normoxia. Both groups of hmDC expressed similar levels of surface markers and cytokines. However, expression of MMP‐9 and membrane type‐1‐MMP, as well as migrating activity, was significantly suppressed in hmDC differentiated under hypoxia compared with their normoxia counterparts. We also demonstrated that trichostatin A restored the production of MMP‐9 in hmDC, under hypoxia. Collectively, our findings show that a hypoxic microenvironment suppresses the production of MMP in hmDC, most probably through the deacetylation of promoter regions of MMP, thus suppressing the migrating activity of hmDC. Our results suggest that the hypoxic microenvironment in solid tumor tissues may suppress the function of DC.

[1]  C. Lewis,et al.  Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. , 2004, Blood.

[2]  Zhi-su Liu,et al.  Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma. , 2004, Chinese medical journal.

[3]  Chun-chung Lee,et al.  Berberine Inhibits HIF-1α Expression via Enhanced Proteolysis , 2004 .

[4]  B. Aggarwal,et al.  A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NFκB motif drives the transition from a repressed to an activated state of gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  S. Saccani,et al.  Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.

[6]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[7]  C. Lewis,et al.  Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. , 2003, The American journal of pathology.

[8]  A. Belldegrun,et al.  LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen. , 2003, Cancer research.

[9]  N. Tamaki,et al.  Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. , 2003, The American journal of pathology.

[10]  M. Asaka,et al.  Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis , 2003, Oncogene.

[11]  P. Ratcliffe,et al.  The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. , 2003, Seminars in cancer biology.

[12]  Y. Osugi,et al.  Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. , 2002, Blood.

[13]  G. Schuler,et al.  Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. , 2002, Journal of immunological methods.

[14]  Y. St-Pierre,et al.  Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. , 2002, Biochemical and biophysical research communications.

[15]  H. Emonard,et al.  Matrix-directed regulation of pericellular proteolysis and tumor progression. , 2002, Seminars in cancer biology.

[16]  G. Schuler,et al.  Matrix Metalloproteinases 9 and 2 Are Necessary for the Migration of Langerhans Cells and Dermal Dendritic Cells from Human and Murine Skin1 , 2002, The Journal of Immunology.

[17]  S. Kondo,et al.  Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. , 2002, Carcinogenesis.

[18]  F. Di Virgilio,et al.  Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. , 2002, Blood.

[19]  G. Randolph.  Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. , 2001, Seminars in immunology.

[20]  M. Asaka,et al.  Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. , 2001, Cancer research.

[21]  Ira Mellman,et al.  Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.

[22]  P. Vaupel,et al.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.

[23]  E. Ohlstein,et al.  Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit. , 2001, Life sciences.

[24]  P. Triozzi,et al.  Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer , 2000, Cancer.

[25]  G. Saed,et al.  Effect of Hypoxia on Stimulatory Effect of TGF-β1 on MMP-2 and MMP-9 Activities in Mouse Fibroblasts , 2000, The Journal of the Society for Gynecologic Investigation: JSGI.

[26]  T. Macdonald,et al.  Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[27]  J. Pouysségur,et al.  Angiogenesis: how a tumor adapts to hypoxia. , 1999, Biochemical and biophysical research communications.

[28]  A. Harris,et al.  Macrophage responses to hypoxia: relevance to disease mechanisms , 1999, Journal of leukocyte biology.

[29]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[30]  Jaw-Yuan Wang,et al.  Specialized Surface Protrusions of Invasive Cells, Invadopodia and Lamellipodia, Have Differential MT1‐MMP, MMP‐2, and TIMP‐2 Localization , 1999, Annals of the New York Academy of Sciences.

[31]  A. Harris,et al.  The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target , 1998, Cancer and Metastasis Reviews.

[32]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[33]  Adrian L. Harris,et al.  Targeting gene expression to hypoxic tumor cells , 1997, Nature Medicine.

[34]  J. Hamada,et al.  A Possible Role of 92 kDa Type IV Collagenase in the Extramedullary Tumor Formation in Leukemia , 1995, Japanese journal of cancer research : Gann.

[35]  Y. Okada,et al.  Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. , 1993, Journal of cell science.

[36]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[38]  D. Carbone,et al.  Tumor-host immune interactions and dendritic cell dysfunction. , 2004, Advances in cancer research.

[39]  N. Romani,et al.  A close-up view of migrating Langerhans cells in the skin. , 2002, The Journal of investigative dermatology.

[40]  N. Romani,et al.  Migration of dendritic cells into lymphatics-the Langerhans cell example: routes, regulation, and relevance. , 2001, International review of cytology.

[41]  G. Dachs.  Targetting gene expression of hypoxic cells , 1997 .